fructosamine has been researched along with mosapride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asakawa, A; Inui, A; Kasuga, M; Komatsu, Y; Kotani, K; Nishimura, R; Takao, F; Ueno, N | 1 |
1 trial(s) available for fructosamine and mosapride
Article | Year |
---|---|
Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus.
Topics: Base Sequence; Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; DNA Primers; Female; Fructosamine; Gastrointestinal Agents; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Morpholines; Placebos; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Receptor Agonists | 2002 |